Literature DB >> 17980599

Breaking news: high-speed race ends in arrest--how oncogenes induce senescence.

Raffaella Di Micco1, Marzia Fumagalli, Fabrizio d'Adda di Fagagna.   

Abstract

Oncogene activation in normal cells induces a permanent proliferative arrest known as cellular senescence. This phenomenon restrains the expansion of cells that bear an activated oncogene and acts as a powerful tumor-suppressive process. Although the full molecular mechanisms are still being elucidated, it has been observed recently that some oncogenes alter the DNA-replication process and cause DNA-damage accumulation. DNA-damage checkpoint-response activation together with the increased appearance of heterochromatin formation that leads to transcriptional silencing of proliferative genes are, presently, the two main mechanisms known that establish and maintain oncogene-induced senescence. Here, we discuss the most recent advancements in understanding the molecular and cellular mechanisms that control cellular senescence caused by oncogene activation and their impact on cancer studies.

Entities:  

Mesh:

Year:  2007        PMID: 17980599     DOI: 10.1016/j.tcb.2007.07.012

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  31 in total

1.  Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.

Authors:  Jim Jinn-Chyuan Sheu; Bin Guan; Jung-Hye Choi; Athena Lin; Chia-Huei Lee; Yi-Ting Hsiao; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Mechanisms of oncogene-induced genomic instability.

Authors:  Simona Graziano; Susana Gonzalo
Journal:  Biophys Chem       Date:  2016-11-24       Impact factor: 2.352

3.  Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker.

Authors:  Takao Kinjo; Julia Ham-Terhune; Jean-Marie Peloponese; Kuan-Teh Jeang
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 4.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

5.  ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation.

Authors:  Yi Chieh Lim; Hazel Quek; Carolin Offenhäuser; Shazrul Fazry; Andrew Boyd; Martin Lavin; Tara Roberts; Bryan Day
Journal:  J Neurooncol       Date:  2018-03-21       Impact factor: 4.130

6.  Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.

Authors:  Caterina Nardella; Zhenbang Chen; Leonardo Salmena; Arkaitz Carracedo; Andrea Alimonti; Ainara Egia; Brett Carver; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

7.  Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.

Authors:  Christina Batsi; Soultana Markopoulou; George Vartholomatos; Ioannis Georgiou; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Mech Ageing Dev       Date:  2009-05-03       Impact factor: 5.432

8.  Sin3B expression is required for cellular senescence and is up-regulated upon oncogenic stress.

Authors:  Kathryn B Grandinetti; Petar Jelinic; Teresa DiMauro; Jessica Pellegrino; Rubén Fernández Rodríguez; Patricia M Finnerty; Rachel Ruoff; Nabeel Bardeesy; Susan K Logan; Gregory David
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 9.  The cullin7 E3 ubiquitin ligase: a novel player in growth control.

Authors:  Antonio Sarikas; Xinsong Xu; Loren J Field; Zhen-Qiang Pan
Journal:  Cell Cycle       Date:  2008-10-04       Impact factor: 4.534

10.  Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism.

Authors:  Vera Gorbunova; Christopher Hine; Xiao Tian; Julia Ablaeva; Andrei V Gudkov; Eviatar Nevo; Andrei Seluanov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.